The Ehlers-Danlos syndrome: On beyond collagens

Journal of Clinical Investigation

Volumn 107, Issue 9, 2001, Pages 1063-1069

  Mao, Jau Ren ^a   Bristow, James ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; TENASCIN;

CLINICAL FEATURE; COLLAGEN METABOLISM; CONNECTIVE TISSUE DISEASE; DISEASE CLASSIFICATION; EHLERS DANLOS SYNDROME; GENE MUTATION; HISTOPATHOLOGY; HUMAN; MOLECULAR DYNAMICS; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

EID: 0035023583     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI12881     Document Type: Review

References (39)

1. The Ehlers-Danlos Syndrome
2. Disorders of collagen biosynthesis and structure
3. Ehlers-Danlos syndromes: Revised nosology, Villefranche, 1997
4. Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type
5. An exon skipping mutation of a type V collagen gene (COL5A1) in Ehlers-Danlos syndrome
6. Mutations of the alpha2(V) chain of type V collagen impair matrix assembly and produce ehlers-danlos syndrome type I
7. COL5A1 haploinsufficiency is a common molecular mechanism underlying the classical form of EDS
8. Null alleles of the COL5A1 gene of type V collagen are a cause of the classical forms of Ehlers-Danlos syndrome (types I and II)
9. Collagen fibrillogenesis in vitro: Interaction of types I and V collagen regurates fibril diameter
10. Type V collagen: Molecular structure and fibrillar organization of the chicken alpha 1(V) NH2-terminal domain, a putative regulator of corneal fibrillogenesis
11. Physical properties of the skin in the Ehlers-Danlos syndrome
12. Decorin interacts with fibrillar collagen of embryonic and adult human skin
13. The discoidin domain receptor tyrosine kinases are activated by collagen
14. A splice-junction mutation in the region of COL5A1 that codes for the carboxyl propeptide of pro alpha 1(V) chains results in the gravis form of the Ehlers-Danlos syndrome (type I)
15. COL5A1: Fine genetic mapping and exclusion as candidate gene in families with nail-patella syndrome, tuberous sclerosis 1, hereditary hemorrhagic telangiectasia, and Ehlers-Danlos Syndrome type II
16. The pro-alpha3(V) collagen chain: Complete primary structure, expression domains in adult and developing tissues, and comparison to the structures and expression domains of the other types V and XI procollagen chains
17. The tenascin family of ECM glycoproteins: Structure, function and regulation during embryonic development and tissue remodeling
18. Mice develop normally without tenascin
19. Skin wounds and severed nerves heal normally in mice lacking tenascin-C
20. Mice deficient in tenascin-R display alteration of the extracellular matrix and decreased axonal conduction velocities in the CNS
21. Transcript encoded on the opposite strand of the human steroid 21-hydroxylase/complement component C4 gene locus
22. Tenascin-X: A novel extracellular matrix protein encoded by the human XB gene overlapping P450c21B
23. The distribution of tenascin-X is distinct and often reciprocal ro that of tenascin-C
24. Distinct tissue distribution in pigs of tenascin-X and tenascin-C transcripts
25. Mechanism and consequences of the duplication of the human C4/P450c21/gene X locus
26. Tenascin-X deficiency is associated with Ehlers-Danlos Syndrome
27. Reversible unfolding of fibronectin type III and immunoglobulin domains provides the structural basis for stretch and elasticity of titin and fibronectin
28. Cell adhesion to tenascin-X mapping of cell adhesion sites and identification of integrin receptors
29. Type III collagen is crucial for collagen I fibrillogenesis and for normal cardiovascular development
30. Targeted mutation in the co15a2 gene reveals a regulatory role for type V collagen during matrix assembly
31. Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility
32. Fibromodulin-null mice have abnormal collagen fibrils, tissue organization, and altered lumican deposition in rendon
33. Lumican regulates collagen fibril assembly: Skin fragility and corneal opacity in the absence of lumican
34. The effects of proteoglycans on the morphology of collagen fibrils formed in vitro
35. Mice that lack thrombospondin 2 display connective tissue abnormalities that are associated with disordered collagen fibrillogenesis, an increased vascular density, and a bleeding diathesis
36. Primary mesenchymal cells isolated from SPARC-null mice exhibit altered morphology and rates of proliferation
37. Thrombospondins as matricellular modulators of cell function
38. SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury
39. DNA arrays for analysis of gene expression